GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease
Phase 2 study testing tominersen in Huntington's disease.
Active, not recruitingPhase 2DrugClinicalTrials.govTreatment trial
Recruiting in: Aachen, Amherst, Angers +66 more (Argentina, Australia, Austria +12 more)
Sponsor: Hoffmann-La Roche
Preparing a short plain-English summary.